The Pharmaceutical CDMO and CRO Services industry on FinBizNet covers 11 listed companies, with broker-view summaries, sub-industry segmentation, latest quarterly results and peer comparisons for each constituent.
| Listed companies | 11 |
|---|---|
| Combined market cap | ₹4,91,435 Cr |
| Median P/E (profitable companies) | 73.5 |
| Median return on equity | 10.1% |
| Companies with latest quarterly results | 11 of 11 |
| Company | Market Cap | P/E | ROE | Quarterly Revenue | Quarterly Net Profit | Quarter |
|---|---|---|---|---|---|---|
| Divis Laboratories Limited | ₹3,01,758 Cr | 118.4 | 16.2% | ₹3,676 Cr | ₹1,127 Cr | Q2 FY27 |
| Anthem Biosciences Limited | ₹53,926 Cr | 90.1 | 19.4% | ₹594 Cr | ₹211 Cr | Q2 FY27 |
| Sai Life Sciences Limited | ₹40,755 Cr | 116.1 | 15.1% | ₹659 Cr | ₹98 Cr | Q2 FY27 |
| Onesource Specialty Pharma Limited | ₹18,138 Cr | — | -1.3% | ₹516 Cr | ₹57 Cr | Q2 FY27 |
| Cohance Lifesciences Ltd | ₹17,756 Cr | 100.6 | 5.1% | ₹477 Cr | ₹2 Cr | Q2 FY27 |
| Syngene International Ltd. | ₹17,630 Cr | 56.9 | 6.6% | ₹833 Cr | ₹32 Cr | Q2 FY27 |
| Jubilant Pharmova Ltd | ₹15,556 Cr | 39.1 | 6.0% | ₹2,370 Cr | ₹31 Cr | Q2 FY27 |
| Concord Biotech Ltd | ₹12,495 Cr | 24.2 | 13.5% | ₹309 Cr | ₹70 Cr | Q2 FY27 |
| Blue Jet Healthcare Ltd | ₹10,140 Cr | 38.0 | 19.9% | ₹376 Cr | ₹103 Cr | Q2 FY27 |
| Dishman Carbogen Amcis Ltd | ₹2,744 Cr | 28.0 | 1.6% | ₹507 Cr | ₹-67 Cr | Q2 FY27 |
| Rays of Belief Limited | ₹536 Cr | 90.6 | — | ₹27 Cr | ₹3 Cr | Q2 FY27 |
Market data from the FinBizNet stock universe; quarterly figures in ₹ crore, parsed from each company's exchange filing (XBRL).
FinBizNet tracks 11 listed companies in the Pharmaceutical CDMO and CRO Services industry, including Divis Laboratories Limited, Anthem Biosciences Limited, Sai Life Sciences Limited, Onesource Specialty Pharma Limited, Cohance Lifesciences Ltd, Syngene International Ltd., Jubilant Pharmova Ltd, Concord Biotech Ltd, among others.
By market capitalisation, the largest Pharmaceutical CDMO and CRO Services companies are Divis Laboratories Limited (₹3,01,758 Cr), Anthem Biosciences Limited (₹53,926 Cr), Sai Life Sciences Limited (₹40,755 Cr), Onesource Specialty Pharma Limited (₹18,138 Cr), Cohance Lifesciences Ltd (₹17,756 Cr).
The 11 Pharmaceutical CDMO and CRO Services companies tracked on FinBizNet have a combined market capitalisation of about ₹4,91,435 Cr.
The median price-to-earnings ratio across 10 profitable Pharmaceutical CDMO and CRO Services companies is 73.5, and the median return on equity across the industry is 10.1%. Medians are shown for context only.
FinBizNet aggregates broker research, sub-industry breakdowns, quarterly results and peer-stock comparisons across the Pharmaceutical CDMO and CRO Services industry.